Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancer

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 74, Issue 4, 2006, Pages 235-245

  Jiang, Wen G ^a   Watkins, Gareth ^a   Douglas Jones, Anthony ^b   Mansel, Robert E ^a  

^a University Department of Surgery   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; ESTROGEN RECEPTOR; ISOPROTEIN;

ARTICLE; BREAST; BREAST CANCER; CANCER CELL; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

ARACHIDONATE 15-LIPOXYGENASE; BREAST; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN;

EID: 33645966798     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.01.009     Document Type: Article

References (45)

1. Sigal E., Craik C.S., Highland E., Grunberger D., Costello L.L., Dixon R.A.F., and Nadel J.A. Molecular cloning and primary structure of human 15-lipoxygenase. Biochem. Biophys. Res. Commun. 157 (1988) 457-464
2. Brash A.R., Boeglin W.E., and Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. 94 (1997) 6148-6152
3. Yoshimoto T., Suzuki H., Yamamoto S., Takai T., Yokoyama C., and Tanabe T. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. Proc. Natl. Acad. Sci. 87 (1990) 2142-2146
4. Kelavkar U.P., and Badr K.F. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene. Proc. Natl. Acad. Sci. 96 (1999) 4378-4383
5. Gonzalez A.L., Roberts R.L., Massion P.P., Olson S.J., Shyr Y., and Shappell S.B. 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Hum. Pathol. 35 (2004) 840-849
6. Kelavkar U.P., and Cohen C. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells. Neoplasia 6 (2004) 41-52
7. Kelavkar U.P., Nixon J.B., Cohen C., Dillehay D., Eling T.E., and Badr K.F. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22 (2001) 1765-1773
8. Tang S., Bhatia B., Maldonado C.J., Yang P., Newman R.A., Liu J., Chandra D., Traag J., Klein R.D., Fischer S.M., Chopra D., Shen J., Zhau H.E., Chung L.W., and Tang D.G. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J. Biol. Chem. 277 (2002) 16189-16201
9. Hsi L.C., Wilson L.C., and Eling T.E. Opposing effects of 15-lipoxygenase-1 and-2 metabolites on MAPK signaling in prostate-alteration in peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 277 (2002) 40459-40556
10. Xu X.C., Shappell S.B., Liang Z., Song S., Menter D., Subbarayan V., Iyengar S., Tang D.G., and Lippman S.M. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia 5 (2003) 121-127
11. Wu J., Xia H.H., Tu S.P., Fan D.M., Lin M.C., Kung H.F., Lam S.K., and Wong B.C. 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitor-induced apoptosis in gastric cancer. Carcinogenesis 24 (2003) 243-247
12. Nixon J.B., Kim K.S., Lamb P.W., Bottone F.G., and Eling T.E. 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot. Essent. Fatty Acids 70 (2004) 7-15
13. Hsi L.C., Kamitani H., Cornicelli J.A., and Eling T.E. Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells. Prostaglandins Leukot. Essent. Fatty Acids 64 (2001) 217-225
14. Chen G.G., Xu H., Lee J.F., Subramaniam M., Leung K.L., Wang S.H., Chan U.P., and Spelsberg T.C. 15-hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int. J. Cancer 107 (2003) 837-843
15. Reddy N., Everhart A., Eling T., and Glasgow W. Characterization of a 15-lipoxygenase in human breast carcinoma BT-20 cells: stimulation of 13-HODE formation by TGF(alpha)/EGF. Biochem. Biophys. Res. Commun. 231 (1997) 111-116
16. Shureiqi I., Chen D., Lee J.J., Yang P., Newman R.A., Brenner D.E., Lotan R., Fischer S.M., and Lippman S.M. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J. Natl. Cancer Inst. 92 (2000) 1136-1142
17. Shappell S.B., Gupta R.A., Manning S., Whitehead R., Boeglin W.E., Schneider C., Case T., Price J., Jack G.S., Wheeler T.M., Matusik R.J., Brash A.R., and Dubois R.N. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res. 61 (2001) 497-503
18. Jiang W.G., Douglas-Jones A., and Mansel R.E. Level of expression of lipoxygenase-5, 12, and 15 and cyclooxygenase in human breast cancer. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 275-281
19. Jiang W.G., Douglas-Jones A., and Mansel R.E. Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int. J. Cancer 106 (2003) 752-757
20. Jiang W.G., Bryce R.P., Horrobin D.F., and Mansel R.E. Peroxisome proliferator activated receptor-gamma mediates the effects of gamma linolenic acid in cancer cells. Prostagladins Leukot. Essent. Fatty Acids 62 (2000) 119-127
21. Kelavkar U.P., Nixon J.B., Cohen C., Dillehay D., Eling T.E., and Badr K.F. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22 (2002) 1765-1773
22. Nazarenko I.A., Bhatnagar S.K., and Hohman R.J. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res. 25 (1997) 2516-2521
23. Jiang W.G., Watkins G., Lane J., Douglas-Jones A., Cunnick G.H., Mokbel M., and Mansel R.E. Prognostic value of Rho familty and rho-GDIs in breast cancer. Clin. Cancer Res. 9 (2003) 6432-6440
24. Jiang W.G., Davies G., Martin T.A., Parcc C., Watkins G., Mason M.D., Mokbel K., and Mansel R.E. Molecular targeting of matrilysin and its impact on tumour growth in vivo, the potential implications in breast cancer therapy. Clin. Cancer Res. 11 (2005) 6012-6019
25. Jiang W.G., Watkins G., Martin T.A., Sampson J., Lee-Jones L., Kefah M., and Mansel R.E. The expression of TSC genes in human breast cancer. Eur. J. Cancer 41 (2005) 1628-1636
26. Ravalli S., Marboe C.C., D'Agati V.D., Michler R.E., Sigal E., and Cannon P.J. Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 340-348
27. Harats D., Ben-Shushan D., Cohen H., Gonen A., Barshack I., Goldberg I., Greenberger S., Hodish I., Harari A., Varda-Bloom N., Levanon K., Grossman E., Chaitidis P., Kuhn H., and Shaish A. Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter. Cancer Lett. 229 (2005) 127-134
28. Liu C., Xu D., Sjoberg J., Forsell P., Bjorkholm M., and Claesson H.E. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp. Cell Res. 297 (2004) 61-67
29. Bull A.W., Branting C., Bronstein J.C., Blackburn M.L., and Rafter J. Increases in 13-hydroxyoctadecadienoic acid dehydrogenase activity during differentiation of cultured cells. Carcinogenesis 14 (1993) 2239-2243
30. Silverman A.L., Bronstein J.C., Krymgold S., Kahlon D., and Bull A.W. Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies. Cancer Epidemiol. Biomarkers Prev. 5 (1991) 53-56
31. Jiang W.G., Bryce R.P., and Horrobin D.F. Essential fatty acids, the molecular and cellular mechanisms of their anticancer action and clinical implications. Crit. Rev. Oncol./Haematol. 27 (1998) 179-209
32. Bortuzzo C., Hanif R., Kashfi K., Staiano-Coico L., Shiff S.J., and Rigas B. The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells. Biochim. Biophys. Acta 1300 (1996) 240-246
33. Kang L.T., and Vanderhoek J.Y. Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells. Biochim. Biophys. Acta 1256 (1995) 297-304
34. Herrmann J.L., Menter D.G., Beham A., von Eschenbach A., and McDonnell T.J. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp. Cell Res. 234 (1997) 442-451
35. Claria J., Lee M.H., and Serhan C.N. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2 (1996) 583-596
36. Watkins G., Mansel R.E., and Jiang W.G. Reduction of nuclear peroxisome proliferator activated receptor gamma and its co-activator, PGC-1 in human breast cancer. Oncol. Rep. 12 (2004) 483-488
37. Jiang W.G. Regulation of cell adhesion, a central mechanism in the anticancer action of essential fatty acids. Int. J. Mol. Med. 1 (1998) 621-626
38. Jiang W.G., Hiscox S., Hallett M.B., Bryce R., Horrobin D.F., Mansel R.E., and Puntis M.C.A. Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. Int. J. Oncol. 9 (1996) 279-284
39. Nunez-Delicado E., Sanchez-Ferrer A., and Garcia-Carmona F. Hydroperoxidative oxidation of diethylstilbestrol by lipoxygenase. Arch. Biochem. Biophys. 348 (1997) 411-414
40. Nishizawa Y., Nishii K., Nishizawa Y., Koga M., Kishimoto S., Matsumoto K., and Sato B. Effects of estrogen on cell proliferation and leukotriene formation in transformed mouse Leydig cells cultured under serum-free conditions. Cancer Res. 50 (1990) 3866-3871
41. Fisch B., Rose M.P., Elder M.G., Winston R.M., Margara R.A., and Hillier S.G. Effects of oestrogen on progesterone synthesis and arachidonic acid metabolism in human luteal cells. Clin. Endocrinol. (Oxford) 40 (1994) 21-32
42. Chang W.C., Nakao J., Orimo H., Tai H.H., and Murato S.I. Stimulation of 12-lipoxygenase activity in rat platelets by 17 beta-estradiol. Pharmacol. 31 (1982) 2633-2638
43. Jiang W.G., Martin T.A., and Mansel R.E. Molecular detection of micro-metastasis in breast cancer. Crit. Rev. Oncol./Hematol. 43 (2002) 13-31
44. Zhang D.H., Tai L.K., Wong L.L., Sethi S.K., and Koay E.S.C. Proteomics of breast cancer: enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 5 (2005) 1797-1805
45. Chu H.W., Balzar S., Westcott J.Y., Trudeau J.B., and Wenzel S.E. 15-lipoxygenase-2 (15-LO-2) expression in bronchial epithelium increased in asthmatic endobronchial tissues. Am. J. Respir. Crit. Care Med. 165 (2002) A556